Board of Directors

Richard N. Kender

Non-Executive Director

Richard N. Kender is an executive with over 35 years of experience in the pharmaceutical industry, most recently as Senior Vice President of Business Development and Corporate Licensing at Merck & Co., Inc. He retired from Merck in 2013. Mr. Kender joined Merck in 1978 and spent his career in various corporate roles including Accounting and Finance, Corporate Licensing and Worldwide Business Development, where he managed Merck‚Äôs Mergers and Acquisitions, Licensing transactions. He also managed the Financial Evaluation and Analysis and Global Competitive Intelligence departments. At Merck, Mr. Kender was involved in over 100 transactions of various size and types. 

Since his retirement from Merck he has served on several corporate Boards. Mr. Kender currently serves on the Board of Directors of Bicycle Therapeutics plc, Poxel S.A. and Seres Therapeutics Inc. He has previously served on the Board of Directors of Abide Therapeutics Inc., and INC Research Holdings Inc. While at Merck he served as a Board Director at FoxHollow Technologies Inc., EV3 Inc. and on the Board of Trustees of BioNJ. 

Mr. Kender earned his B.S. degree in accounting from Villanova University and his M.B.A. from Fairleigh Dickinson University.